Stanford researchers probe drug liking in the operating room
NCT ID NCT07015528
First seen Jan 11, 2026 · Last updated Jun 22, 2026 · Updated 27 times
Summary
This early-phase study at Stanford University is looking at whether the medication droperidol can change how much people like other drugs given during surgery or procedures. About 130 participants will rate their drug liking and sedation levels, and researchers will also measure brain activity. The goal is to better understand drug liking in a clinical setting, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG LIKING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Stanford Hospital
Palo Alto, California, 94304, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Droperidol
What this could lead to
If successful, this could help understand how certain medications influence feelings of drug liking in medical settings.
What could go wrong
This is a very early, small study focused on measuring subjective feelings, not treating a disease. Results may not lead to any practical changes.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.